| Literature DB >> 31428192 |
Wei Ren1,2, Yanshuai Ding1,3, Lide Gu1,3, Wanli Yan1,3, Cang Wang1,3, Mingsheng Lyu1,4,3, Changhai Wang2,3, Shujun Wang1,4,3.
Abstract
BACKGROUND: Layered double hydroxides (LDHs) have received widespread attention for their potential applications in catalysis, polymer nanocomposites, pharmaceuticals, and sensors. Here, the mechanism underlying the physiological effects of Mg-Fe layered double hydroxide nanoparticles on the marine bacterial species Arthrobacter oxidans KQ11 was investigated.Entities:
Keywords: Arthrobacter oxidans KQ11; Dextranase; Marine bacteria; Mg–Fe layered double hydroxide nanoparticles; Transcriptional profiling
Year: 2019 PMID: 31428192 PMCID: PMC6696678 DOI: 10.1186/s13068-019-1528-2
Source DB: PubMed Journal: Biotechnol Biofuels ISSN: 1754-6834 Impact factor: 6.040
Fig. 1Growth curves of A. oxidans KQ11 batch cultures that were chronically exposed to different concentrations of Mg–Fe-LDH NPs
Fig. 2Aodex generation after exposure of A. oxidans KQ11 to different concentrations of Mg–Fe-LDH NPs (A) and at 30 h (B). Columns with different letters indicate statistically significant differences (p < 0.05) between controls and treatments. The error bars represent standard deviations of averages (n = 3)
Fig. 3Characterization of A. oxidans KQ11 cell structure after exposure to 100 mg/L of Mg–Fe-LDH NPs for 30 h using SEM (A, B), TEM (C, D), EDS (E), and EDS mapping (D–I). The yellow arrows show Mg–Fe-LDH NPs attached to cell surfaces (for interpretation of the color references to color in this figure legend, the reader is referred to the web version of this article)
Fig. 4Detection of intracellular Mg and Fe ion concentrations in A. oxidans KQ11 using ICP-AES after exposure to different concentrations of Mg–Fe-LDH NPs. Asterisks (*) represent statistically significant (p < 0.05) differences
Fig. 5Changes in the gene expression of A. oxidans KQ11 cells induced by Mg–Fe-LDH treatment. A Significantly up-regulated genes are shown in red, down-regulated genes in blue, and those not exhibiting significant differences in expression are shown as black dots. The abscissa represents the fold changes in gene expression among different samples, and the ordinate represents the statistical significance of differences in expression change. B Heat map and clustering analysis of transcriptional profiles of genes encoding transcription factors. High expression levels are depicted in red, and low expression levels in blue. Clustering was conducted using log10 (FPKM + 1) values after normalization of expression values
Fig. 6GO enrichment analysis of differentially expressed genes of A. oxidans KQ11 after Mg–Fe-LDH treatment
Fig. 7KEGG pathways represented by enriched differentially expressed genes
Overview of DEGs involved in KEGG pathway
| No. | Pathway ID | DEGs with pathway annotation (19) | All genes with pathway annotation (577) | KEGG pathway | Gene list | KO list | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ko02020 | 3 (15.79%) | 31 (5.37%) | Two-component system | 0.015012085 | 0.03940672 | KQ11_GM000490, KQ11_GM000492, KQ11_GM000491, | K07793, K07795, K07794 |
| 2 | ko00360 | 3 (15.79%) | 13 (2.25%) | Phenylalanine metabolism | 0.000500975 | 0.01052047 | KQ11_GM003846, KQ11_GM003870, KQ11_GM001828, | K00276, K00146, K05710 |
| 3 | ko00260 | 2 (10.53%) | 18 (3.12%) | Glycine, serine and threonine metabolism | 0.018086604 | 0.04220208 | KQ11_GM003846, KQ11_GM000418, | K00276, K13745 |
| 4 | ko01220 | 1 (5.26%) | 9 (1.56%) | Degradation of aromatic compounds | 0.032243512 | 0.06771138 | KQ11_GM001828, | K05710 |
| 5 | ko02060 | 1 (5.26%) | 5 (0.87%) | Phosphotransferase system (PTS) | 0.009694457 | 0.02908337 | KQ11_GM003720, | K02804 |
| 6 | ko02010 | 6 (31.58%) | 63 (10.92%) | ABC transporters | 0.002328422 | 0.01588777 | KQ11_GM003996, KQ11_GM003998, KQ11_GM003995, KQ11_GM000625, KQ11_GM000624, KQ11_GM000623, | K02015, K02016, K02013, K02012, K02011, K02010 |
| 7 | ko00630 | 1 (5.26%) | 32 (5.55%) | Glyoxylate and dicarboxylate metabolism | 0.284432368 | 0.37331748 | KQ11_GM000606, | K01638 |
| 8 | ko00620 | 1 (5.26%) | 29 (5.03%) | Pyruvate metabolism | 0.246513313 | 0.34511864 | KQ11_GM000606, | K01638 |
| 9 | ko00643 | 1 (5.26%) | 3 (0.52%) | Styrene degradation | 0.003026241 | 0.01588777 | KQ11_GM003870, | K00146 |
| 10 | ko00520 | 3 (15.79%) | 27 (4.68%) | Amino sugar and nucleotide sugar metabolism | 0.009121947 | 0.02908337 | KQ11_GM003720, KQ11_GM003723, KQ11_GM003721, | K02804, K01443, K02564 |
| 11 | ko00650 | 1 (5.26%) | 15 (2.60%) | Butanoate metabolism | 0.083581921 | 0.12537288 | KQ11_GM000543, | K01029 |
| 12 | ko00410 | 1 (5.26%) | 2 (0.35%) | Beta-Alanine metabolism | 0.00102903 | 0.01080481 | KQ11_GM003846, | K00276 |
| 13 | ko00280 | 1 (5.26%) | 12 (2.08%) | Valine, leucine and isoleucine degradation | 0.055721077 | 0.1063766 | KQ11_GM000543, | K01029 |
| 14 | ko00640 | 1 (5.26%) | 15 (2.60%) | Propanoate metabolism | 0.083581921 | 0.12537288 | KQ11_GM000991, | K18382 |
| 15 | ko00350 | 1 (5.26%) | 13 (2.25%) | Tyrosine metabolism | 0.064571367 | 0.11299989 | KQ11_GM003846, | K00276 |
| 16 | ko00072 | 1 (5.26%) | 5 (0.87%) | Synthesis and degradation of ketone bodies | 0.009694457 | 0.02908337 | KQ11_GM000543, | K01029 |
Fig. 8Secondary structures of sRNA1, sRNA2, sRNA3, and sRNA4 of A. oxidans KQ11 following Mg–Fe-LDH NP treatment. The sRNAs were located on the plas2, plas3, plas1, and plas1 regions of the A. oxidans KQ11 chromosome, respectively
Fig. 9Proposed mechanism of the effects of Mg–Fe layered double hydroxide nanoparticles on the physiological functioning of A. oxidans KQ11